In Silico Design, Molecular Docking, Molecular Dynamics Simulation, and ADMET Evaluation of Novel Quinazoline Derivatives as EGFR Inhibitors for Non-Small-Cell Lung Cancer. AMAR. 2026;4(6):26-71. doi:10.5281/zenodo.21820790